SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-109667
Filing Date
2008-05-09
Accepted
2008-05-09 15:31:41
Documents
7
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 543180
2 INSPIRE PHARMACEUTICALS, INC. EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFIT PLAN dex101.htm EX-10.1 86627
3 INSPIRE PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE BENEFIT PLAN dex102.htm EX-10.2 75142
4 SECTION 302 PRESIDENT AND CEO CERTIFICATION dex311.htm EX-31.1 9307
5 SECTION 302 CFO AND TREASURER CERTIFICATION dex312.htm EX-31.2 9310
6 SECTION 906 PRESIDENT AND CEO CERTIFICATION dex321.htm EX-32.1 3702
7 SECTION 906 CFO AND TREASURER CERTIFICATION dex322.htm EX-32.2 3705
  Complete submission text file 0001193125-08-109667.txt   732390
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 08818188
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1